Drug‐induced gingival enlargement: Biofilm control and surgical therapy with gallium–aluminum–arsenide (GaAlAs) diode laser—A 2‐year follow‐up

Guaré, Renata de Oliveira; Costa, Soraya Carvalho; Baeder, Fernando Martins; Merli, Luiz Antonio de Souza; Santos, Maria Teresa Botti Rodrigues

doi:10.1111/j.1754-4505.2009.00126.x

Cited by 20 publications

(11 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 Nonsurgical periodontal treatment (including oral hygiene instruction, scaling, root planing, and prophylaxis) is the conventional management approach for gingival enlargement but is not always effective when gingival enlargement is extensive and self-care is compromised. 12 This in turn has led to surgical approaches to the management of gingival enlargement. However, this is considered by many as very invasive and may not be effective if self-care oral hygiene practices remain poor.…”

Section: Introductionmentioning

confidence: 99%

The adjunct effectiveness of diode laser gingivectomy in maintaining periodontal health during orthodontic treatment

Rabie

Wong

et al. 2012

The Angle Orthodontist

View full text Add to dashboard Cite

Objective: To evaluate the effectiveness of diode laser gingivectomy as an adjunct to nonsurgical periodontal treatment in the management of periodontal health among patients receiving fixed orthodontic appliance therapy (FOAT). Materials and Methods: Thirty patients undergoing FOAT with gingival enlargement were block randomized into two treatment groups. The test group received diode laser gingivectomy (940-nm diode laser, ezlase, Biolase Technology Inc) as an adjunct to nonsurgical periodontal treatment. The control group received nonsurgical periodontal treatment only. For both groups, five periodontal parameters were assessed at baseline, 1 month, 3 months, and 6 months: Plaque Index, Gingival Index, bleeding on probing, probing pocket depth, and Gingival Overgrowth Index. Intra- and intergroup variations in the periodontal parameters were determined over time. Results: Both groups showed statistically significant improvements in periodontal health over the study period (P < .05). However, significant improvements in periodontal health were evident earlier among the test group subjects (P < .05). The magnitude of improvement in periodontal health compared to baseline was greater in the test group than in the control group for Gingival Overgrowth Index at 1 month (P < .001) and 3 months (P < .05), Gingival Index at 3 months (P < .05) and 6 months (P < .05), and probing pocket depth at 1 month (P < .05). Conclusions: Nonsurgical periodontal management with or without the adjunct use of lasers can be effective in the management of gingival health problems among patients receiving FOAT. The adjunctive use of lasers can produce an earlier and greater improvement in gingival health.

show abstract

Section: Introductionmentioning

confidence: 99%

The adjunct effectiveness of diode laser gingivectomy in maintaining periodontal health during orthodontic treatment

Rabie

Wong

et al. 2012

The Angle Orthodontist

View full text Add to dashboard Cite

show abstract

“…Reported cases of gingival enlargements were induced by different drugs; CCBs (50/119 – of which amlodipine-25;[8910111213141516171819202122232425262728] nifedipine-13;[26293031323334353637383940] verapamil-4;[41] felodipine-2;[4243] nisoldipine-1;[44] manidipine-1;[45] and unspecified CCBs-4[46]); phenytoin (11/119);[4748495051525354555657] cyclosporine (31/119);[3546585960616263646566676869707172737475] phenobarbital (4/119);[767778] sodium valproate (3/119 - including one report of congenital drug-induced gingival hyperplasia);[798081] d-penicillamine (2/119);[82] combination oral contraceptive pill-lynestrenol and ethinyl estradiol (1/119);[83] vigabatrin (1/119). [84] Cases of gingival enlargement after combination drug therapy have also been reported; a combination of cyclosporine and CCBs (11/119);[354685...…”

Section: Resultsmentioning

confidence: 99%

Drug-induced gingival overgrowth: A critical insight into case reports from over two decades

Samudrala

Chava

Chandana

et al. 2016

J Indian Soc Periodontol

View full text Add to dashboard Cite

Drug-induced gingival overgrowth (DIGO) is a well-recognized adverse effect of certain systemic medications. Calcium channel blockers, anticonvulsants, and immunosuppressants are frequently implicated drugs in the etiology of DIGO. Drug variables, plaque-induced inflammation, and genetic factors are the three important factors in the expression of gingival changes after systemic medication use. Careful clinical examination and thorough history taking form the basis for diagnosis of DIGO. Histopathological examination is often neglected; however, it is an important aid that helps in differential diagnosis. Cessation or change of drug and meticulous plaque control often leads to regression of the lesion, which however might need surgical correction for optimal maintenance of gingival health. The purpose of the present article is to review case reports and case series published in the last two decades and to assimilate and compile the information for clinical applications such as diagnosis and therapeutic management of DIGO.

show abstract

“…The use of mouth rinses is a useful adjunctive self-care approach to the management of gingival enlargement, but it, too, relies on patient compliance; in addition, there can be some side effects with long-term use (29). Nonsurgical periodontal treatment (including oral hygiene instruction, scaling, root planing, and prophylaxis) is the conventional management approach for gingival enlargement but is not always effective when gingival enlargement is extensive and self-care is compromised (30).…”

Section: Adjunct Procedures For Periodontal Therapymentioning

confidence: 99%

Laser Therapy for Soft Tissue Management in Orthodontics

2016

View full text Add to dashboard Cite

Context: In recent years, lasers have numerous applications in orthodontics as an important field of dentistry. The purpose of this article is to review some of the major applications of laser in the field of soft tissue management in orthodontics. Evidence Acquisition: No single laser wavelength can be used to optimally treat all dental diseases. However, the needs of the orthodontic clinician are unique and selection of the most appropriate laser for orthodontic applications is essential to achieve optimal results. Results: Light emitted from diode lasers is poorly absorbed by dental hard tissues, these lasers can be safely used for soft tissue surgery applications, including gingival recontouring, crown lengthening, removal of hypertrophic tissue and frenectomies close to the enamel, dentine and cement. Considering beam safety, most of the lasers used for medical and dental purposes are in the Class IV category, so it is necessary to take appropriate safety measures. Conclusions: In the near future, with the clarification of laser exposure protocols and a decrease in device cost and, Dental lasers may play an increasingly important role in soft tissue management during orthodontic treatment.

show abstract

Drug‐induced gingival enlargement: Biofilm control and surgical therapy with gallium–aluminum–arsenide (GaAlAs) diode laser—A 2‐year follow‐up

Cited by 20 publications

References 29 publications

The adjunct effectiveness of diode laser gingivectomy in maintaining periodontal health during orthodontic treatment

The adjunct effectiveness of diode laser gingivectomy in maintaining periodontal health during orthodontic treatment

Drug-induced gingival overgrowth: A critical insight into case reports from over two decades

Laser Therapy for Soft Tissue Management in Orthodontics

Contact Info

Product

Resources

About